<DOC>
	<DOCNO>NCT00721136</DOCNO>
	<brief_summary>Patients require long term anticoagulation often undergo transition warfarin heparin anticipation invasive surgical procedure pacemaker ICD implantation . This may require inpatient hospitalization several day prior procedure , potentially increase medical cost patient inconvenience . Patients undergo process initiate heparin INRs drift normal level . Immediately prior surgery , heparin discontinue restart several hour procedure . Unfortunately , process result high incidence surgical wound hematoma bleed complication often require long period discontinue anticoagulation repeat surgical exploration . Previous investigator try reduce incidence wound hematomas prolonging time surgical wound closure reinitiation heparin . A small randomized trial demonstrate significant difference incidence wound hematoma whether heparin start 6 hour 24 hour surgery ( J Am Coll Cardiology 2000 ; 35:1915-8 ) . This lead many investigator perform pacemaker ICD implantation without reversal warfarin therapy . A recent retrospective observational study demonstrate incidence wound hematoma patient INR 2.6 different patient INR 1.5 ( PACE 2004 ; 27:358-60 ) . Furthermore , recent , large retrospective observational study report abstract form recent Heart Rhythm Society Annual 2007 Scientific Meeting demonstrate perform pacemaker ICD implantation safe without reverse warfarin anticoagulation , incidence wound hematomas significantly small compare strategy reverse warfarin initiate periprocedural heparin . Given finding , hypothesis randomize study pacemaker ICD implantation fully anticoagulated warfarin therapy safe . Findings study significant implication clinical practice pacemaker ICD implantation patient population give randomize study subject perform date .</brief_summary>
	<brief_title>Randomized Study Use Warfarin During Pacemaker ICD Implantation Patients Requiring Long Term Anticoagulation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>schedule clinically indicated permanent pacemaker implantable cardioverterdefibrillator currently chronic warfarin therapy unwilling participate trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>bleeding</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>pacemaker</keyword>
	<keyword>implantable cardioverter-defibrillator</keyword>
	<keyword>patient undergo implantation pacemaker defibrillator ( ICD ) ''</keyword>
</DOC>